Employer Wellness Lab Panels: What to Include and How to Run Them

An employer wellness lab panel is a short set of blood tests, usually paired with biometric measurements and a health questionnaire, that gives employees a snapshot of their health risks. A well-built panel covers lipids and glucose at minimum, adds a few targeted tests, keeps results private, and ends with a clear path to a physician for anything abnormal. This guide walks through each decision, from test selection to legal guardrails, so you can plan a program that employees trust and use.

TL;DR

• Workplace screenings typically combine three parts: a health risk questionnaire, biometric measurements, and blood testing, most often cholesterol and glucose.
• Choose fasting or non-fasting based on the tests you want: fasting adds LDL and triglycerides, and it shapes how you schedule the day.
• Participation must be voluntary, and the ADA, GINA and HIPAA limit incentives and how results are shared. Employers should see only aggregate data.
• A screening result is a flag, not a diagnosis. Build follow-up with a physician into the plan before the first draw.
• Pick a laboratory partner that can handle collection, courier pickup, fast reporting and secure delivery of results.

What an employer wellness lab panel is

A wellness panel is a screening tool, not a diagnostic workup. The American College of Occupational and Environmental Medicine describes workplace biometric screening as generally having three components: a health risk assessment questionnaire with self-reported lifestyle data, biometric measurements such as height, weight, BMI and blood pressure, and blood testing that commonly includes cholesterol and glucose.

The difference from diagnostic testing is purpose. A diagnostic order starts with a patient’s symptoms or a physician’s question. A wellness panel starts with a population: it looks for risk in people who may feel fine, then points them toward care. That is why the panel design, the consent process and the follow-up matter as much as the tests themselves.

For employers, the panel also serves a second reader. Aggregate, de-identified results can show where a workforce is trending, which helps you decide which health education or benefits to offer next.

Which blood tests belong on the panel

The core: lipids and glucose

Research on employer-sponsored health risk assessments shows what most programs actually measure. A PLOS One study of 52,270 participants found that when lab tests are included, they are typically limited to total cholesterol, a lipid panel (total cholesterol, HDL, calculated LDL and triglycerides) and fasting glucose. The same study found that testing for other common conditions, such as chronic kidney disease, is less typical, even though the lab data did identify newly found cases of hyperlipidemia, diabetes and chronic kidney disease.

That gives you a sensible baseline:

• Lipid panel: total cholesterol, HDL, LDL and triglycerides, for cardiovascular risk.
• Glucose or hemoglobin A1C: for diabetes and prediabetes risk.
• Blood pressure and BMI: the biometric measurements that sit beside the blood work.

If you want a dedicated lipid workflow for your population, see our lipid testing page.

Useful additions

Once the core is in place, many employers add a handful of tests. ACOEM notes that hemoglobin A1C, thyroid-stimulating hormone and serum cotinine can be run from finger-stick blood collected on a card and shipped to a laboratory. Beyond those, consider:

• Complete blood count (CBC): Cleveland Clinic’s executive health reference guide explains that hemoglobin can point toward anemia and that white blood cell count is elevated in inflammation or infection.
• Thyroid (TSH): per the same guide, an increased TSH may indicate hypothyroidism, and a decreased value may indicate hyperthyroidism.
• Hepatitis C antibody: the guide lists a one-time screening for all adults, which lines up with the U.S. Preventive Services Task Force grade B recommendation for adults 18 to 79 (more on that below).
• CRP and vitamin B12: the guide associates elevated CRP with future cardiovascular risk and links B12 deficiency to anemia and nervous system problems.

More markers are not automatically better. Each added test creates more results that need interpretation and more people who may need follow-up. If you are curious how far biomarker panels can go and where their reach ends, this overview of what longevity biomarkers measure is a helpful companion read.

Anchor the panel to preventive guidelines

The U.S. Preventive Services Task Force publishes A and B recommendations that make a good checklist for what deserves a place on a panel:

The JOEM article on biometric screening for employers notes that the Task Force does not issue recommendations specifically for employers. Treat the list above as a reference point for your workforce’s age and risk mix, and let your medical director or consulting physician make the final call on content.

Fasting or non-fasting: a scheduling decision

The choice affects both the data and the logistics. According to ACOEM, non-fasting panels include glucose, total cholesterol and HDL, while fasting panels add LDL and triglycerides. Blood can be drawn by finger stick or from a vein.

A few practical points:

• Fasting gives you a fuller lipid picture, but it asks employees to arrive without eating, which can lower turnout and create problems for people with certain conditions or medications. Tell employees up front to ask their own physician if they are unsure whether fasting is right for them.
• Non-fasting is easier to attend, and it still delivers cholesterol and glucose figures you can act on.
• If you fast, schedule early. The JOEM article recommends putting fasting screenings at the start of employees’ shifts and generally keeping them to a four-hour window.

Whatever you choose, give employees written instructions in plain language. We keep copy-ready wording on our fasting requirements for biomarkers page that you can adapt for reminders and confirmation emails.

What the results can and cannot tell you

Employees often read an out-of-range number as a diagnosis. Your communication should say, clearly and kindly, that it is not one. The PLOS One authors use the phrase “newly identified” rather than “diagnosed” because a medical risk is not diagnosed until it is confirmed, usually with testing on a second specimen and after other causes of the finding are excluded. In their words, laboratory results are only part of the diagnostic pathway, and further medical evaluation is required.

That framing is reassuring as well as accurate. A flagged glucose or LDL is a prompt to see a physician early, when there are usually more options. For a related look at how clinicians match follow-up to risk and lab findings, see this piece on psychiatry follow-up and lab rules.

For results that are markedly abnormal, set up a protocol in advance with your consulting physician or laboratory partner so that nobody receives an alarming value in an envelope with no next step.

Rules that shape a compliant program

Workplace screening sits at the intersection of several federal laws. This is general information, not legal advice. Have employment counsel and your benefits advisor review the program design.

Voluntary participation and incentives

Under the EEOC’s 2016 final rules (effective 2017), wellness programs that are part of a group health plan and include medical examinations or health questions may offer incentives of up to 30 percent of the total cost of self-only coverage. Under the GINA rule, the incentive tied to a spouse’s participation may not exceed that amount, and no incentives are allowed in exchange for children’s health information or specified genetic information. The OPM fact sheet Considerations for Screenings adds that participants should be free to accept or decline any component without fear of consequences, and should receive an orientation so they know what to expect.

Genetic information

The same OPM fact sheet states that Title II of GINA makes it illegal to discriminate based on genetic information, and that health risk appraisals should not ask about family medical history unless the parameters of 29 CFR 1635.8 are carefully followed. Keep your questionnaire clean of family history questions unless counsel signs off.

Privacy of results

The EEOC’s sample notice says personally identifying medical information will not be provided to supervisors or managers or used to make employment decisions, and that employees will not be required to waive confidentiality to participate or earn an incentive. The EEOC final rules add that information may reach employers only in aggregate terms, and that employees must receive a notice describing what is collected, who sees it, why, and how it is kept confidential.

The JOEM article describes a clean data flow:

• The participant receives all of their own results.
• The employer receives aggregate, de-identified data showing risk stratification.
• A health management company or physician receives data only with appropriate participant consent.
• Every transfer happens through a secure, HIPAA-compliant channel.

If you want to understand how de-identification works in practice, our guide to HIPAA de-identification methods explains the two recognized paths.

State direct-access rules

JOEM also notes that a few states clearly prohibit direct access testing and require a physician’s order for tests to be run and reported. Confirm the rule in each state where you have employees, and make sure your laboratory partner arranges the physician oversight required.

Planning the screening day

Staffing and throughput

The JOEM article gives a rule of thumb: four to six people can be screened per staff member per hour. For a 200-person site with a four-hour window, that works out to roughly eight to twelve collection staff-hours per hour of… in plain terms, divide your headcount by the number of people each phlebotomist can handle across your window, then add a buffer for late arrivals and re-draws. Multi-shift and multi-site employers usually need more than one session.

Orientation and communication

OPM recommends an orientation so employees understand the screening. A one-page notice, a short FAQ and a named contact for questions will do more for turnout than a larger incentive. Cover what is measured, whether to fast, who sees results, and what happens if a value is out of range.

Participation and follow-up

The CDC’s integrated approach to worker safety, health and well-being rests on six characteristics, including participation at every level, comprehensive strategies, and data-driven change where regular evaluation guides decisions. Applied to screening, that means involving employees and any organized labor in planning, then reviewing the aggregate data each year to adjust the panel.

Track a few measures: participation by site and shift, how many employees with a flagged result saw a physician, and how many return next year. The OPM fact sheet notes strong evidence that screenings with feedback, combined with health education, can improve health behaviors or conditions in employee groups. The feedback and the education are the parts that make the screening worthwhile.

Choosing a laboratory partner

The laboratory behind the program determines whether the day runs smoothly and whether results are trustworthy and private. When you compare options, whether a national chain, a hospital lab or an independent laboratory, check these points:

• Collection model: can they draw on site or arrange mobile phlebotomy, and handle specimen pickup?
• Turnaround and reporting: how quickly do results come back, and how do employees and physicians receive them?
• Integration: can results flow into the EMR or LIS your clinical partners already use?
• Privacy architecture: can they deliver aggregate, de-identified reporting to the employer and individual results only to the participant and their physician?
• Panel flexibility: can the panel be customized to your population rather than fixed?
• Support: is there a person you can reach when something goes wrong?

Our wellness panels page shows how we organize panels for wellness programs, and our full test menu covers the broader range of testing.

Our perspective

We work with wellness programs, medical practices and research organizations, and the same lesson keeps showing up: the panel is the easy part. What decides whether a screening helps people is what happens in the days after the draw.

That is why we build around speed, direct communication and customization. Our approach is to give each program a laboratory partner who answers the phone, adjusts the panel to the population and delivers results electronically, so physicians and participants can act while the screening is still fresh in people’s minds.

We also think employers should lean on the clinical side early. Our services include phlebotomy, specimen pickup, provider portal access, electronic results reporting and EMR integration, so the practices that receive your employees’ follow-up visits can work with the same data. Done well, a workplace screening becomes a bridge between a person’s job and their primary care.

Kohealth Labs

Bring your wellness panel to a laboratory built for it

If you are designing a screening for a company, a wellness program or a clinic network, we can help you scope the panel, the collection logistics and the results workflow. Our services include mobile phlebotomy, courier specimen pickup, electronic results reporting and integration with your clinical systems.

Explore our wellness panels or contact us through our website to talk through your program.

FAQ

What is typically included in an employer wellness lab panel?

Most panels pair biometric measurements with blood tests for cholesterol (total, HDL, and often LDL and triglycerides) and glucose. Many programs add hemoglobin A1C, thyroid-stimulating hormone or a complete blood count. The right mix depends on your workforce’s age and risk profile and on guidance from a physician.

Do employees have to take part?

No. Participation must be voluntary under federal guidance, and employees can decline any component without fear of consequences. Incentives are allowed within the EEOC limits, but an employee cannot be required to waive confidentiality to earn one.

What can an employer see about an individual’s results?

Employers should see only aggregate, de-identified data, and personally identifying medical information must not go to supervisors or managers. Individual results go to the employee, and to a physician with the employee’s consent.

Should the screening be fasting or non-fasting?

Fasting panels add LDL and triglycerides to glucose, total cholesterol and HDL, but they require early scheduling and clear instructions. Non-fasting panels are easier to attend and still give useful cholesterol and glucose values. Employees with questions about fasting should ask their own physician.

What happens when a result is abnormal?

An abnormal result is a reason for further evaluation, not a diagnosis. Plan ahead so that employees get their results privately, with a clear recommendation to see their physician and, where appropriate, a person who can help them book the visit.

Sources

• ACOEM: Biometric Health Screening for Employers (position statement, 2013)
• PLOS One: Value of Laboratory Tests in Employer-Sponsored Health Risk Assessments (2011)
• Cleveland Clinic: Executive Health Reference Guide (2022)
• U.S. Preventive Services Task Force: A and B Recommendations
• JOEM: Biometric Health Screening for Employers (2013)
• EEOC: Final Rules on Employer Wellness Programs (2016)
• EEOC: Sample Notice for Employer-Sponsored Wellness Programs
• OPM: Considerations for Screenings fact sheet
• CDC: Implementing an Integrated Approach
• Longevity Biomarkers: What They Measure and What They Can’t Tell You
• Match Visits to Risk: Psychiatry Follow Up by Phase and Lab Rules

For more information about our diagnostic testing, clinical research laboratory services, or partnership opportunities, visit https://kohealthlabs.com or contact KoHealth Labs at (469) 792-8439 and ask for Amy Patterson.